Document is current
Any future updates will be listed below
-
Authors
Katsuyama, Eri
Humbel, Morgane
Suarez-Fueyo, Abel
Satyam, Abhigyan
Yoshida, Nobuya
Kyttaris, Vasileios C. https://orcid.org/0000-0001-7652-3826
Tsokos, Maria G. https://orcid.org/0000-0001-8072-1358
Tsokos, George C. https://orcid.org/0000-0001-9589-2360
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (RO1AI42269)
- License Information
-
More Information
Article History
Received: 11 December 2021
Accepted: 17 September 2024
First Online: 27 September 2024
Competing interests
: GCT is on the scientific advisory boards of Cugene, Biolojic, ABPRO, A2 biotherapeutics, COREVITAS. VCK is site PI for clinical trial for BMS, Astra Zeneca and Novartis. VK is advisory board member for Janssen and Aurinia. VK is in the clinical trial adjudication committee member for Cabaletta. ASF currently employed at Abbvie. The remaining authors declare no competing interests.
